D T Steimel - JoVE Visualize

Showing results (1-10 of 8) with videos related to

Pageof 1

Sort By:

European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 21, 2000

Analysis of drug transport and metabolism in cell monolayer systems that have been modified by cytochrome P4503A4 cDNA-expressionC L Crespi, L Fox, P Stocker, et al.

Molecular Carcinogenesis|January 1, 1990

Stable expression of human cytochrome P450IA2 cDNA in a human lymphoblastoid cell line: role of the enzyme in the metabolic activation of aflatoxin B1C L Crespi, D T Steimel, T Aoyama, et al.

Carcinogenesis|February 1, 1991

The development of a human cell line stably expressing human CYP3A4: role in the metabolic activation of aflatoxin B1 and comparison to CYP1A2 and CYP2A3C L Crespi, B W Penman, D T Steimel, et al.

Mutagenesis|March 1, 1997

Development of a human lymphoblastoid cell line constitutively expressing human CYP1B1 cDNA: substrate specificity with model substrates and promutagensC L Crespi, B W Penman, D T Steimel, et al.

Chemical Research in Toxicology|September 1, 1991

A metabolically competent human cell line expressing five cDNAs encoding procarcinogen-activating enzymes: application to mutagenicity testingC L Crespi, F J Gonzalez, D T Steimel, et al.

Pharmacogenetics|January 26, 1999

Detection and characterization of novel polymorphisms in the CYP2E1 geneK S Fairbrother, J Grove, I de Waziers, et al.

Carcinogenesis|August 1, 1990

Human cytochrome P450IIA3: cDNA sequence, role of the enzyme in the metabolic activation of promutagens, comparison to nitrosamine activation by human cytochrome P450IIE1C L Crespi, B W Penman, J A Leakey, et al.

Pharmacogenetics|August 1, 1995

Comparison of substrate metabolism by wild type CYP2D6 protein and a variant containing methionine, not valine, at position 374C L Crespi, D T Steimel, B W Penman, et al.

Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:

Pageof 1

European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 21, 2000

Analysis of drug transport and metabolism in cell monolayer systems that have been modified by cytochrome P4503A4 cDNA-expressionC L Crespi, L Fox, P Stocker, et al.

Molecular Carcinogenesis|January 1, 1990

Stable expression of human cytochrome P450IA2 cDNA in a human lymphoblastoid cell line: role of the enzyme in the metabolic activation of aflatoxin B1C L Crespi, D T Steimel, T Aoyama, et al.

Carcinogenesis|February 1, 1991

The development of a human cell line stably expressing human CYP3A4: role in the metabolic activation of aflatoxin B1 and comparison to CYP1A2 and CYP2A3C L Crespi, B W Penman, D T Steimel, et al.

Mutagenesis|March 1, 1997

Development of a human lymphoblastoid cell line constitutively expressing human CYP1B1 cDNA: substrate specificity with model substrates and promutagensC L Crespi, B W Penman, D T Steimel, et al.

Chemical Research in Toxicology|September 1, 1991

A metabolically competent human cell line expressing five cDNAs encoding procarcinogen-activating enzymes: application to mutagenicity testingC L Crespi, F J Gonzalez, D T Steimel, et al.

Pharmacogenetics|January 26, 1999

Detection and characterization of novel polymorphisms in the CYP2E1 geneK S Fairbrother, J Grove, I de Waziers, et al.

Carcinogenesis|August 1, 1990

Human cytochrome P450IIA3: cDNA sequence, role of the enzyme in the metabolic activation of promutagens, comparison to nitrosamine activation by human cytochrome P450IIE1C L Crespi, B W Penman, J A Leakey, et al.

Pharmacogenetics|August 1, 1995

Comparison of substrate metabolism by wild type CYP2D6 protein and a variant containing methionine, not valine, at position 374C L Crespi, D T Steimel, B W Penman, et al.

Pageof 1